Price $256.83 |
Market Cap
191.82B
|
Sector Health Care |
Div. Growth
16.70%
|
|
P/E
30.6
|
P/B
4.34
|
P/S
6.17
|
Dividend %
0.40%
|
|
P/CF
-
|
P/FCF
30.0
|
Op. Cash Flow
8.46M
|
FCF
8.7
|
|
Op. Margin
24.90%
|
Net Margin
20.80%
|
ROE
15.30%
|
ROI
9.60%
|
|
ROA
7.70%
|
EPS Growth
36.10%
|
Current Ratio
1.4
|
Debt/Equity
52.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc (ETON) | $2.96 | - | - | 76.7M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.92 | - | - | 61.3M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.25 | - | - | 77.5M | Strong Buy |
| Compugen Ltd. (USA) (CGEN) | $2.09 | - | - | 159.9M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
